Mats Ekelund
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Precision medicine in neurodegeneration: the IHI-PROMINENT project.
Journal: Frontiers in neurology
Published: February 28, 2023
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden.
Journal: Journal of medical economics
Published: May 10, 2021
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 14, 2020
Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden.
Journal: PharmacoEconomics
Published: February 05, 2019
An open prospective study evaluating efficacy and safety of a new medical device for rectal application of activated carbon in the treatment of chronic, uncomplicated perianal fistulas.
Journal: International journal of colorectal disease
Published: November 18, 2016
Direct and indirect costs for anal fistula in Sweden.
Journal: International journal of surgery (London, England)
Published: August 01, 2016
A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.
Journal: Journal of medical economics
Published: June 11, 2014
All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.
Journal: PloS one
Published: May 28, 2014
To the Editor; A Commentary on "Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden".
Journal: Biologics in therapy
Published: January 15, 2014
A higher score on the dermatology life quality index, being on systemic treatment and having a diagnosis of psoriatic arthritis is associated with increased costs in patients with plaque psoriasis.
Journal: Acta dermato-venereologica
Published: April 23, 2013
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Journal: Clinical therapeutics
Published: December 02, 2012
Last Updated: 09/26/2026